Odyssey Intraocular Lens for Cataracts
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new type of lens, the TECNIS Odyssey intraocular lens, for individuals with cataracts who previously underwent LASIK surgery for nearsightedness. The goal is to assess how well these lenses improve vision at various distances and gauge patient satisfaction. The trial seeks participants with cataracts in both eyes who are scheduled for cataract surgery and have a history of LASIK surgery. As a Phase 4 trial, it involves an FDA-approved lens, confirming its safety and effectiveness, and aims to understand how it can benefit more patients.
Will I have to stop taking my current medications?
The trial excludes participants using any systemic or topical drugs known to interfere with visual performance, so you may need to stop certain medications. It's best to discuss your current medications with the trial team to see if they are affected.
What is the safety track record for the TECNIS Odyssey intraocular lens?
Research has shown that the TECNIS Odyssey intraocular lens (IOL) is generally safe and well-tolerated. Studies have found that it reliably improves vision for people with cataracts. This lens is designed to perform well in various lighting conditions and aids in clear vision at different distances.
However, evidence regarding its effectiveness in enhancing contrast sensitivity (such as distinguishing between different shades of light and dark) and patient-reported experiences is moderate to low. While many patients report positive outcomes, further research is needed to fully understand the lens's performance in all situations.
Overall, the TECNIS Odyssey IOL is considered safe. Prospective trial participants should discuss any concerns with their doctor.12345Why are researchers enthusiastic about this study treatment?
The TECNIS Odyssey intraocular lens is unique because it offers improved visual outcomes for cataract patients by providing enhanced depth of focus. Unlike standard monofocal lenses, which typically focus on a single distance, the Odyssey lens is designed to enhance vision across a range of distances, potentially reducing the need for glasses. Researchers are excited about this treatment because it aims to improve overall patient satisfaction and quality of life by delivering sharper, more versatile vision with fewer visual disturbances compared to existing options.
What evidence suggests that the TECNIS Odyssey intraocular lens is effective for cataracts?
Research shows that the TECNIS Odyssey intraocular lens (IOL), which participants in this trial will receive, effectively improves vision for people with cataracts. It uses over 95% of available light, providing sharp and clear vision. Studies have found that it delivers consistent results, even with small focusing errors in the eye. The lens also allows clear vision at different distances, making it easier to focus on objects both near and far. This feature is especially useful for those with presbyopia, a common vision issue with age. Overall, the TECNIS Odyssey IOL offers a dependable option for better vision after cataract surgery.12367
Who Is on the Research Team?
Joaquin K De Rojas, MD
Principal Investigator
Center For Sight
Are You a Good Fit for This Trial?
This trial is for individuals who have had LASIK surgery to correct myopia (nearsightedness) and are now in need of cataract surgery. The study specifically looks at how well a new type of intraocular lens, the TECNIS Odyssey IOL, works in their unique eyes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Implantation of the TECNIS Odyssey intraocular lens (IOL) in patients with a history of myopic LASIK
Follow-up
Participants are monitored for visual and refractive outcomes, including distance, intermediate, and near vision, and patient satisfaction
What Are the Treatments Tested in This Trial?
Interventions
- TECNIS Odyssey intraocular lens
Trial Overview
The focus of this study is on the TECNIS Odyssey intraocular lens performance post-implantation in patients with previous myopic LASIK. It aims to evaluate visual outcomes across various distances and overall patient satisfaction with the new lens.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Center For Sight
Lead Sponsor
Sengi Clinical
Collaborator
Citations
Johnson & Johnson Rolls Out New TECNIS Odyssey Next- ...
TECNIS Odyssey IOL offers higher tolerance to residual refractive errors, enabling surgeons to deliver consistent and reliable patient outcomes.
TECNIS Odyssey™ IOL | J&J Vision Professional
The effectiveness of TECNIS Odyssey ™ Toric II IOLs in reducing postoperative residual astigmatism in patients with preoperative corneal astigmatism <1.0 ...
Early Clinical Results of a Newly Developed Continuous ...
This retrospective review included 50 eyes of 25 patients with cataracts who underwent bilateral implantation of modified CRV IOLs (models ...
4.
jnjmedtech.com
jnjmedtech.com/en-US/news-events/johnson-johnson-celebrates-milestone-100k-tecnis-odyssey-iols-implanted-2025-americanJohnson & Johnson Celebrates a Milestone of 100K TECNIS ...
TECNIS ODYSSEY IOL delivers over 95% of light utilization,1 supporting image quality2 3 4 and visual acuity, giving patients sharp, clear vision ...
5.
clearvisionforyou.com
clearvisionforyou.com/en-us/news-media-center/releases/new-max-odyssey-data-arvo/New Scientific Data from Johnson & Johnson at ARVO 2025
Compared to an aspheric monofocal lens, the TECNIS Odyssey ™ IOLs mitigate the effects of presbyopia by providing improved visual acuity at intermediate and ...
6.
clearvisionforyou.com
clearvisionforyou.com/en-us/news-media-center/releases/odyssey-iol-optical-performance/TECNIS Odyssey: Fastest-Growing PCIOL in the United ...
Robust data evaluating TECNIS Odyssey demonstrates outstanding patient outcomes with the new intraocular lens.
7.
jnjmedtech.com
jnjmedtech.com/en-EMEA/news-events/johnson-johnson-showcases-new-data-tecnis-iols-escrs-2025Johnson & Johnson Showcases New Data for TECNIS™ IOLs ...
Evidence for contrast sensitivity and patient-reported outcomes was moderate to low, with further research needed on other new enhanced ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.